ABIOMED Inc
NASDAQ:ABMD
ABIOMED Inc
Cash from Investing Activities
ABIOMED Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ABIOMED Inc
NASDAQ:ABMD
|
Cash from Investing Activities
-$162.9m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Investing Activities
-$1.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-2%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Investing Activities
-$2.4B
|
CAGR 3-Years
-108%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-16%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Investing Activities
-$1.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
See Also
What is ABIOMED Inc's Cash from Investing Activities?
Cash from Investing Activities
-162.9m
USD
Based on the financial report for Sep 30, 2022, ABIOMED Inc's Cash from Investing Activities amounts to -162.9m USD.
What is ABIOMED Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-1%
Over the last year, the Cash from Investing Activities growth was 35%. The average annual Cash from Investing Activities growth rates for ABIOMED Inc have been -5% over the past three years , -1% over the past five years .